H5N1 Avian Bird Flu

Company in the news

Moderna gets US$590 mil from US to study bird flu vaccine

The version of the virus spreading in North America right now has led to only a few serious cases, but concerns have been rising since a death was linked to the virus in Louisiana earlier this month.

This new anti-viral drug could beat Ebola, SARS, H5N1 Avian Bird Flu, and more

SINGAPORE (Feb 28): Singapore eDevelopment (SeD) announced Wednesday that its biomedical subsidiary, Global BioLife Inc., has completed the Zaire Ebola virus research portion for the study of a new anti-viral drug called LB2.
×